Clinical Trial Update: Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). [NA]

View source ↗

Summary

This clinical trial update describes the SURTAVI study evaluating the safety and efficacy of Medtronic's CoreValve System for severe symptomatic aortic stenosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• CoreValve System

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Severe Aortic Stenosis | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2019-09-17